Tanzania has confirmed its first two cases of mpox, the health ministry said Monday, the first time the virus has been detected in an outbreak that has hit several African countries.
Implementing opportunistic computed tomography (CT) bone density screening could increase the osteoporosis screening rate, yielding a reduction in medical costs, according to a study published in the March issue of the Journal of the American College of Radiology.
For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for developing hematologic cancers compared with insulin and metformin use, according to a research letter published online March 6 in JAMA Network Open.
A University of Rochester Medical Center study showed that downtime in the emergency room can have a potential upside for women who are behind on cervical cancer screenings, which is a nationwide problem.
Contextual social determinants of health (SDoH)—for example, rural residence and neighborhood economic factors—may affect access to community-based rehabilitation services for older adults with traumatic brain injury (TBI), suggests a study in the March/April issue of Journal of Head Trauma Rehabilitation.
The U.S. Centers for Disease Control and Prevention (CDC) is preparing to study whether vaccines are linked to autism—despite overwhelming scientific evidence showing no connection.
The Wistar Institute’s Paul M. Lieberman, Ph.D. and lab identified and tested a new method for targeting certain cancers caused by Epstein-Barr Virus (EBV), in the paper, “USP7 inhibitors destabilize EBNA1 and suppress EBV tumorigenesis,” from the Journal of Medical Virology.
A novel analysis of more than 375 published studies concluded that the association between chronic pain and rates of depression and anxiety is staggering. The study, led by investigators at Johns Hopkins Medicine found that 40% of adults with chronic pain experienced “clinically significant depression and anxiety.” Among those most at risk, the analysis showed, were women, younger adults and people with fibromyalgia.
Scientists at the Wisconsin National Primate Research Center (WNPRC) and the Morgridge Institute for Research at the University of Wisconsin–Madison have been at the forefront of stem cell research and regenerative biology since James Thomson isolated the first human embryonic stem cell in 1998.